Chorvátsko - chorvátčina - HALMED (Agencija za lijekove i medicinske proizvode)

alcon farmaceutika d.o.o., zagreb - pomoć pri operacijama u prednjem segmentu oka uključujići ekstrakciju katarakte i ugradnje intraokularne leće

Čierna Hora - chorvátčina - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

društvo za spoljnu i unutrašnju trgovinu, zastupanje, posredovanje, inženjering i usluge "businessmontenegro" podgorica - neaktivna implantabilna medicinska sredstva

Čierna Hora - chorvátčina - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

"netpharm" druŠtvo sa ograniČenom odgovornoŠĆu za zastupanje, spoljnu i unutraŠnju trgovinu podgorica - medicinska sredstva za jednokratnu upotrebu

Čierna Hora - chorvátčina - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

druŠtvo za trgovinu na veliko farmaceutskim proizvodima "farmax" doo danilovgrad - medicinska sredstva za zaštitu pacijenata i sredstva za inkontinenciju (isključujući ličnu zaštitnu opremu - ppe)

Európska únia - chorvátčina - EMA (European Medicines Agency)

astrazeneca ab - durvalumab - karcinom, ne-malih stanica pluća - antineoplastična sredstva - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).

Európska únia - chorvátčina - EMA (European Medicines Agency)

astrazeneca ab - tremelimumab - carcinoma, hepatocellular - antineoplastična sredstva - imjudo in combination with durvalumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc). imjudo in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.

Európska únia - chorvátčina - EMA (European Medicines Agency)

accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastična sredstva - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.

Európska únia - chorvátčina - EMA (European Medicines Agency)

ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - antineoplastična sredstva - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.

Chorvátsko - chorvátčina - HALMED (Agencija za lijekove i medicinske proizvode)

beckman coulter d.o.o., zagreb - in vitro dijagnostički sistem, hematološki brojač, analizator

Chorvátsko - chorvátčina - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

intervet international b.v., podružnica u rh, ivana lučića 2a, 10000 zagreb, republika hrvatska - inaktivirana lawsonia intracellularis, soj spah-08 - liofilizat i otapalo za emulziju za injekciju, za svinje - svinja